Top 5 Metrics for Winning More Studies: Part 2

 

Last week we featured the Top 5 Metrics for Winning More Studies, Part 1. In part 2 of our feature, we’ll introduce you to the Devana Solutions IGNITE platform for Sites. IGNITE is an easy-to-use software platform that simplifies the complex pipeline management process by consolidating all trial opportunities in one place.  IGNITE makes the management of business development, contact management, start-up activities, study execution and performance metrics easier and faster.

Purpose & Value Proposition.

Benefits:

  1. An end to end solution to easily capture data, or manage data form other systems such as CTMS.
  2. Track and report all timing and performance metrics.
  3. One custom platform for transparency, efficiency and accountability.
  4. Better data helps operations to:
    • Identify bottlenecks, implement improvements and performance benchmarks
    • Increase revenue by negotiating from a position of strength, trend identification and optimizing trial opportunities.
    • Demonstrate reliability, predictability and accountability to Sponsors/CROs.
    • Use data trends to allocate resources, develop new capabilities and identity areas for growth.

Trial Milestone Tracking & Reporting.

Benefits:

  1. Customized milestones and workflows to manage entire start up process.
  2. Real-time metrics and reports on individual and aggregate trial performance.
  3. Current recruitment numbers, enrollment rate and contract percentage.
  4. Trial stage automatically advances as milestones are completed.
  5. Compare internal vs. Sponsor/CRO timelines for key milestones.
  6. Track key budget and negotiation details.
  7. Automated and custom reminders and tasks assigned to staff for key milestones.

Timing and Performance Metrics Reports.

Benefits:

  1. Combined trial data for analysis and trend identification.
  2. 100+ standard reports.
  3. Unlimited custom reports
  4. Export, print, or create a visual dashboard.
  5. View data for any time-frame.

Real-Time Study Status Reports.

 

Benefits:

  1. View full study pipeline, stage and compare progress across all sites.
  2. Full visibility of workflows and next steps across the team- saves time and reduces risk.
  3. Establish benchmarks to improve efficiency and measure improvement.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms, IGNITE, PROPEL and IQ for sponsors and cros, to provide historical and real-time data capture, aggregation and display to drug development stakeholders.

For questions and to schedule an introductory call or demo, contact Barry Lake, CEO & Co-Founder.

Barrylake@devanasolutions.com

(301) 471-6962

Top 5 Metrics for Winning More Studies: Part 1

Metrics in a Changing Site Landscape

Today’s research organizations face more challenges than ever before. Cycle time reduction, operational efficiency and standardization, revenue growth, and regulatory needs are increasing the complexity of site operations.

Many research organizations look to operational data and metrics to track, manage, and ultimately improve their performance in key areas. As Sponsors/CROs collect data on sites for their own use, it’s even more important for a site to know their own metrics.

While there are hundreds of data points and metrics that can be measured, they typically fall into the categories of timing or performance metrics.

Key timing and performance metrics are then used to find bottlenecks and establish benchmarks to improve operational efficiency, and to help win more study awards through demonstrating a site’s predictability and reliability to a Sponsor/CRO.

Here are the top five metrics used by research organizations successfully winning more awards aligned with their capabilities using the Devana Solutions operations and analytics platform.

 

#1 – Time from Award to Active

Why Track?

This metric, measured in number of days, demonstrates that your site can mobilize quickly, and reflects the level of organization and efficiency a Sponsor/CRO can expect from your site.

 

What to Measure?

The Site Activation Date – The Date of Award = The Time from Award to Active in days. Calculate the average or median across all trials.

 

Bonus Tip!

Not impressed with your site’s performance data? Use the data to reflect an improvement. Is there a positive trend (Ex. 25% reduction in the last 2 years)?

 

#2 – Days from Active to Screening

Why Track?

This metric, also measured in number of days, shows that once a site is activated, they are immediately screening patients. This is reflective of a thoroughly planned and executed Patient Recruitment Strategy.

 

What to Measure?

The Date of First Patient Screened – Site Activation Date = The Days from Active to Screening. Calculate the average or median across all trials.

 

Bonus Tip!

As trials can have unexpected delays out of a site’s control, measure days from Site Activation rather than Start Date. Once Activated, there are fewer variables that can impact a site’s timing.

 

#3 – Contract Met Percentage by Indication

Why Track?

Almost half (49%) of sites awarded a trial either under enroll or do not enroll at all.

As the saying goes: “past performance is the best predictor of future success.” This metric represents a site’s historical enrollment performance within an indication and is one of the best predictors of expected enrollment.

Showing that the contracted number of patients within an indication is met, or even exceeded, reduces the risk to the Sponsor/CRO in awarding a trial to your site.

 

What to Measure?

By Indication: Completed Number of Patients / Contracted Number of Patients x 100 = The Contract Met Percentage on the Trial. Calculate the percentage across all trials in the same indication.

 

Bonus Tips!

Track the Primary and Secondary Indications to have options in reporting, and more relevant data.

Once you’re tracking completed trials, start measuring currently running trials to see trends.

Determine your trends! How does this metric look as a 2-year average? 12 months? Across all historical trials?

 

#4 – Patients Completed, Screened and Enrolled by Primary Indication

Why Track?

Three different metrics: 1) Patients that have Completed a Study; 2) Patients who have been Screened; and 3) Patients Enrolled. Patients Completed or Screened are more likely to participate in a trial which – from the perspective of a Sponsor/CRO – means a site should not have enrollment issues and is likely to enroll faster.

Patients Enrolled shows current performance in that indication and, simultaneously, that the site is not overextended in that indication.

 

What to Measure?

Completed Number of Patients from all historical trials, by Primary Indications.

All Patients Screened for a primary indication, track by Primary Indications.

Patients Enrolled on all current trials within Primary Indications.

 

Bonus Tip!

Track Secondary Indications as well for options in reporting and more relevant data.

 

#5 – Studies in Indication by PI and Site

Why Track?

Demonstrates the experience of the PI and site within the indication which communicates experience and confidence to the Sponsor/CRO. Experience within the indication can also mean quicker enrollment or certainty of reaching or exceeding contracted enrollment.

Tracking pending, enrolling and completed trials tells a story of the ability of the PI and site to deliver results, and shows that other Sponsors/CROs have trusted the organization with their study.

 

What to Measure?

For each PI and site, track studies in the pipeline, in progress, and completed. Track the primary indication and any relevant secondary indications for each study for help with filtering future search results.

 

Bonus Tips!

Also track the Sponsor/CRO on each study to show indication experience with those specific organizations.

Track other relevant PI experience such as having been a Sub Investigator, certifications, credentials, awards and recognition, interest in other indications, and for new PI’s, track those interested in doing research.

 

Recommendations and Next Steps

Having the data and metrics through tracking all relevant associated trial details such as CRO, Sponsor, Indication, etc. provides options on how to tell your site’s story when seeking trial awards from Sponsors and CROs.

Metrics for winning awards are part of the larger pool of Site Operations Metrics. To win more awards, track and analyze your site’s key timing and performance metrics.

The best time to plant a tree is 20 years ago, the second-best time is today! If you don’t have historical data, start now! Most organizations only provide two years or less of performance metrics.

Start small with the five key metrics provided, but if you want even more awards and site efficiency now, Devana Solutions can import any historical data and have a site automatically capturing new metrics within a few weeks.

Research organizations using the Devana platform know that our technology and their metrics are proven to standardize workflows, improve communication, cut trial cycle times and win more awards.

Next week, in part 2 of this series, we’ll spotlight a few features of the Devana platform. For questions, or to learn more, explore our website, DevanaSolutions.com, or contact us today.

###

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. www.devanasolutions.com

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

The True Story of the FICO Score – And Why it Matters to Clinical Research Sites

(CHAPEL HILL, NC) – August 15, 2019 (last updated). In recent weeks many of you have heard me making the point that the clinical trial site industry needs more data so that ‘good’ sites can differentiate themselves from ‘bad’ sites.

It would be good for the sites – who will win more business – but more data would also allow CROs a greater ability to select sites that deliver effective clinical trials, ultimately making trials quicker and less costly.

Devana’s IGNITE and PROPEL technology allows important data to be stored and shared by clinical trial sites and site networks as the basis for a scorecard to demonstrate the strength of their performance and case for selection for a clinical trial.

I have often compared the Devana ‘Scorecard’ to the equivalent of a FICO score for the clinical trial site industry. The FICO score is now so commonplace, it struck me that many people do not know the story behind it, the impact it has had on consumer lending and what lessons it holds for the clinical trial site sector.

The FICO score allows banks, credit card companies and other lenders to evaluate the potential risk of lending money to consumers.

Before it existed, lending decisions were based partly on a report prepared on you in utmost secrecy and at the whim of the underwriter at the bank you were applying – apparently the report included such observations as the quality of your furniture and your character!

As ad-hoc and unreliable credit scoring systems were being developed by individual lenders, the FICO Score was developed in 1956 by the engineer William Fair and the mathematician Earl Isaac who had met while working at Stanford. They formed a company Fair, Isaac & Co (the initials of the company spell FICO – which is what the company re-named itself in 2009).

At first, the system was used by individual lenders as private clients of Fair Isaac. The first general purpose FICO score was developed in 1989. Fannie Mae and Freddie Mac began using it in 1995.

To underline how important the FICO score has become in consumer lending, more than 10 BILLION scores are purchased every year by lenders – and more than 100 million Americans have access to their own FICO score.

While the exact formula for calculating a score has never been revealed, we do know it includes weighted consideration of payment history, debt burden, length of credit history, types of credit and recent credit searches.

Just think how much risk has been taken out of lending thanks to the FICO Score.

And consumers, thanks to an amendment to the Fair Credit Reporting Act which passed in 2003, now get free access to their credit reports to gain an understanding of what they need to do to achieve a higher FICO Score to get cheaper loans.

It’s a win-win for both lenders and consumers.

And that’s exactly why we at Devana Solutions believe the clinical trials industry needs that FICO equivalent scorecard for sites and site networks.

The trial sites with good ‘credit’ will use the Devana Scorecard to prove it and win the business they deserve.

Trial sites whose ‘credit’ needs a little mending will know where they need to do to strengthen their game.

And the Sponsors and CROs will have a way of recruiting trial sites that greatly increases site performance predictability and improves clinical trial efficiency and effectiveness.

Another win-win!

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. www.devanasolutions.com

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

ACRP and Devana Solutions® Announce First Annual Site Metrics Challenge Study Winners

(Chapel Hill, NC) – April 13, 2019. The Association of Clinical Research Professionals (ACRP), a non-profit establishing industry standards for clinical research competence and workforce development, and Devana Solutions, provider of cloud-based metrics capture and data analytics software for clinical trial sites and networks, are excited to announce winners of the 2019 Annual Site Metrics Challenge Study. The study analyzed timing and performance metrics data and the impact of clinical site staff-training by accredited organizations such as ACRP, the leader in clinical trials workforce development and certification.

The study was headlined by three industry-leading Integrated Site Networks: IACT Health, a 17-site network throughout Georgia; LMC Manna Research, at 21 integrated sites across Canada; and PMG Research, Inc., ICON’s integrated site network covering 14 cities in the Mid-Atlantic & Midwest regions. Not surprisingly, each of the headlining site networks won in a category and ranked highly in the other metrics categories. Almost 200 investigative sites participated representing single-location research sites, site networks, highly-specialized sites and academic medical centers.

Participants submitted reports focused on five, specific study start-up and performance metrics which, along with a myriad of other data points, were already being automatically tracked and captured through their usage of Devana Solutions® IGNITE platform by the majority of participants.

Winners of the 2019 ACRP-Devana Solutions Site Metrics Challenge Study are:

Fastest Feasibility Turnaround
1st Place: LMC I Manna Research
2nd Place: MedPharmics

Fastest from Activation to First Screen
ForCare Clinical Research

Fastest Budget & Contract Turnaround Time
Winner in the Site Network Category: PMG Research, Inc.
Winner in the AMC Category: University of Sunshine Coast
Winner in the Specialty Site Category: Raleigh Neurology Associates Clinical Research

Contract Met Percentage
IACT Health

“We conceived of the ACRP-Devana Solutions Site Metrics Challenge Study to try to explore and test a thesis,” according to Jim Kremidas, Executive Director of ACRP, “That thesis being that strong site performance would highly correlate to sites and site networks that had a high commitment to ACRP site staffing, training, and development initiatives. We were pleased – but not surprised – to learn that all of the winning sites and site networks had a strong history and commitment to ACRP training and certification across a very high percentage of their site staff.”

“PMG Research is honored to be recognized for our efforts to decrease start up timelines. Making the clinical trials process more efficient benefits industry partners, sites, and patients by maximizing enrollment opportunity, contributing to faster data analysis, and improving time to market,” said Kathy Cole, Director of Feasibility at PMG Research.

“Devana’s technology facilitates more effective and efficient collaboration through a scalable and centralized platform, providing workflow automation, historical analysis, performance metrics, and custom live reporting from anywhere, any time,” said Simon Corman, Director, Business Development at LMC Manna Research.

“IACT Health has long been a proponent of adopting advanced technologies across our sites and of ACRP’s efforts around staffing, training and development,” stated Jeff Kingsley, CEO of IACT Health, “Clearly, both have contributed in supporting the performance of our dedicated team at IACT.”

ACRP and Devana Solutions believe that this year’s winners and participants will continue to raise the bar for clinical research. By recognizing these outstanding sites and celebrating their achievements, the organizations aim to inspire other high-performing sites to advance their education through ACRP’s training and certification and to improve performance through adopting the Devana IGNITE technology to capture and analyze site metrics toward the overall goal of making the Clinical Research Community stronger.

The ACRP – Devana Solutions First Annual Site Metrics Challenge Study winners will be recognized at the 2019 ACRP Annual Meeting Awards & Recognition Ceremony on April 12, 2019 in Nashville, Tennessee.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms, IGNITE, PROPEL and IQ for sponsors and cros, to provide historical and real-time data capture, aggregation and display to drug development stakeholders.

https://devanasolutions.com/

Devana Solutions Announces Performance Level Sponsorship for Inaugural Global Oncology Site Solutions Summit in Austin, Texas

(Chapel Hill, NC) – January 7, 2019.  Devana Solutions® LLC, a software provider driven by a core belief that data transparency through technology is critical to align sites with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease, is pleased to announce its Sponsorship of the SCRS Global Oncology Site Solutions Summit in Austin.  The 2019 Global Oncology Site Solutions Summit takes place from February 2-3 at the Hilton, Austin in Texas. Devana Solutions will be exhibiting at Booth #7.

The Devana vision aligns well with the SCRS Oncology program vision: To cure cancer through efficiency in process and strength in the relationships between clinical research sites, pharmaceutical companies, and patients.  It is the Devana-SCRS shared belief that this conference will provide tremendous value to attendees and sponsors through partnerships between Sponsors, CROs and Sites.

Barry Lake, Devana’s CEO and Co-Founder stated, “Devana is committed to the success of the SCRS Global Oncology Summit. Our team enjoys seeing our clients, meeting new prospects and sharing our solution to enable sites to improve their operational performance and drive toward our shared goal of reducing drug development costs to deliver better outcomes for patients. Oncology is a key therapeutic area of focus for Devana and its partnership with SCRS continues to advance its goals and progress.”

“SCRS is pleased to include Devana Solutions as one of the innovative solution providers in our community.  Since its inception as a transformative innovator in our space, Devana – like so many others in our community — has contributed invaluable expertise and passion. Devana is a dedicated partner to research sites and SCRS.” commented Dawn Baron, Director of Strategic Initiatives for SCRS.

Devana Solutions team members will be on hand at Booth #7 to answer attendee questions and provide demonstrations of the Devana Solutions transformational software platform. Devana’s CEO will also be participating in a panel on Saturday, February 2, 2019 at 4:30 p.m. C.S.T. entitled “Budget Breakdown – Beyond Per-Patient Costs.”. The panel will be facilitated by Molly Downhour, Strategy Executive with Medix Clinical Research, another strategic partner of Devana Solutions, adding value to research sites and site networks.  To Register for this event, visit www.OncologySiteSolutionsSummit.com.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com 

 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com  (608) 285-2151

 

About SCRS

Founded in 2012, SCRS is a global trade organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,000 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, connectivity, and mentorship. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success.  Join the community. Visit mySCRS.org or register at www.OncologySiteSolutionsSummit.com

 

Contact: Sean Soth, sean.soth@myscrs.org (410) 963-2952

ACRP and Devana Solutions Annual Metrics Challenge Study in Analysis Stage

(Washington, DC) – December 17, 2018.   ACRP, a nonprofit that sets standards for clinical research competence has been working in collaboration with Devana Solutions (Devana) and industry-leading Site Networks on a study to analyze research site and network performance data based on workforce qualification.   Said Jim Kremidas, ACRP Executive Director, “In support of ACRP’s workforce development goals, we believe it is critical to analyze site staffing, training and development initiatives and their impact on performance. Since Devana Solutions’ IGNITE for sitessoftware helps sites capture key metrics for display and analysis, it is a natural fit to collaborate with them on this study.”  The Annual Metrics Challenge Study was launched in April at the ACRP Annual Conference and continues through April 12, 2019 when the next conference opens in Nashville. The results of the study will help gain insights into the impact of clinical trial training and development programs on trial site effectiveness.

Each site or site network participating in the Site Metrics Challenge Study, utilizes Devana Solutions’ IGNITE for sites platformfor more efficient study start-up and analytics on historic and current trial performanceDevana Solutions’ IGNITE for sitesis a cloud-based platform allows sites to gather data in real time, analyze the results and decision against the analytics to drive process improvement and select more of the right trials from therapeutically and operationally-aligned industry Sponsors and CROs.  The first round of site performance metrics data was gathered from participating sites last month and will be collected and analyzed twice more before results of the study are revealed at ACRP Nashville in 2019.

The study is being headlined by key Research Networks –including LMC Manna I Research and IACT Health, with several other sites participating as well.  The study is open to any participating research sites who utilize Devana Solutions IGNITEfor sites technology platform

All participants are excited to be part of this ground-breaking work and shared some thoughts about the challenge.   Said Karri Venn, president of LMC Manna, “For over 20 years we have been on the forefront of clinical trial expertise and support the ARCP’s missing of improving efficiency and effectiveness of clinical trial management.   Given we were using the Devana platform, it was natural to work with the other top site networks to demonstrate each company’s efficiency and effectiveness for the good of the industry.” Added Felicia Irvin, VP Sales and Marketing of IACT Health “We stand behind the ACRP and its rigorous training; we pay for it and reward our employees for getting certified.  With the Devana Solutions overlay, we were in a position to help contribute to the ACRP Annual Metrics Challenge Study.”  Another participant of the challenge, Ashley Meinsenheimer from MedPharmics, saw the value of Devana Solutions’ IGNITE for sitesimmediately given her background in managing large datasets.  Meinsenheimer stated “I was pleased to participate in the ACRP challenge because it provided an opportunity for us to benchmark our site network against the best and it also provided an opportunity to demonstrate the usefulness of the technology to our employees.”

Barry Lake, Co-Founder and CEO of Devana stated “We are delighted to align with ACRP and our partner Site Networks to drive to excellence in clinical research through real time data and analytics.  Site performance data transparency to support the industry-leading trial sites and site networks is our sole focus at Devana.”

Full study results will be shared in the Spring of 2019 during the ACRP Annual Conference.

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification.  Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere inthe world. ACRP’s mission is to promote excellence in clinical research.  www.acrpnet.org

Contact:  Jeremy Glunt, media@acrpnet.org(703) 258-3506

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com

 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

Devana Solutions’ IGNITE for sites Technology User Base Continues Rapid Growth; Attesting to the Value of Data Analytics in the Clinical Trials Industry

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.  This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sitestechnology include:

  • Cancer Treatment Centers of America (https://www.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.

 

  • Raleigh Neurology Associates Clinical Research Center(http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.

 

  • University of Washington, Division of Cardiology(https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.

 

  • Javara Research(https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.

 

  • Elias Research Associates(https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites andPROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com 

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

IGNITE for sites Growth Demonstrates Value of Data Analytics in Clinical Trials

(Chapel Hill, NC) – December 10, 2018.   Devana Solutions® LLC, makers of cloud-based performance data transparency software aimed at standardizing and improving Clinical Trial operations at the site level, today announced several new research partners utilizing its powerful IGNITE for sites technology.  These new clients represent single investigative sites, site networks, site management organizations (SMO), a leading integrated research organization, academic research centers, and span a wide range of therapeutic specialties.

“Our core mission is to provide technology to improve site processes and align the top research organizations with trial Sponsors which can dramatically cut trial cycle time, lower development costs and get therapeutic advances to patients faster” stated Barry Lake, CEO of Devana Solutions “That vision is rapidly becoming reality with our platform becoming the choice of the industry leaders in the research site space. We are truly humbled.”

The IGNITE for sites technology is a robust site metrics-capture and data analytics platform that delivers an industry leading solution for clinical trials management – from initial study lead through critical study start-up stages to patient screening and enrollment.   This allows for a more streamlined and efficient approach to clinical trial management – leading to faster cycle times and better outcomes – at lower costs.

Recent new clients being onboarded onto the Devana IGNITE for sites technology include:

  • Cancer Treatment Centers of America (https://beta.cancercenter.com/), a national network of five comprehensive cancer care and research centers and three outpatient centers serving cancer patients throughout the U.S.
  • Raleigh Neurology Associates Clinical Research Center (http://www.raleighneurology.com/), a key player in the development and consequential approval of many cutting-edge treatment options for neurological conditions including MS, Parkinson’s and Alzheimer’s Disease with up to 100 clinical trials in all phases underway at any given time.
  • University of Washington, Division of Cardiology (https://cardiology.uw.edu/about), with over 90 faculty at three hospitals and residence of the “Father of Exercise Cardiology”, Dr. Robert A. Bruce (deceased) who invented the multistage treadmill cardiac stress test in 1963 with the “Bruce Protocol” still taught in medical schools to this day.
  • Javara Research (https://www.javararesearch.com/), a team of luminaries in clinical research who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials with an innovative model of making clinical trials more accessible to patients by fully integrating industry-sponsored clinical trials into major health systems such as Wake Forest Baptist Medical Center.
  • Elias Research Associates (https://www.eliasresearch.com/), a leading Study Management Organization (SMO) providing professional administrative and financial services to accelerate study start-up for specialists across the U.S. in almost every medical indication.About Devana Solutions, LLCDevana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs.  www.devanasolutions.com   

    Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com  (608) 285-2151

Javara chooses Devana IGNITE for sites software platform to fuel its Integrated Research Organization (IRO)

(CHAPEL HILL, NC) – October 18, 2018.   Devana Solutions, LLC (“Devana”) is pleased to join in supporting Javara’s goal of creating a more relevant clinical trial experience for value-oriented healthcare systems and their patients.   With Javara running Devana’s performance data transparency software platform, enhanced predictive clinical research delivery models become a reality, allowing for improved access to cutting edge therapies and better outcomes within patient–centered care across academic medical centers and healthcare systems.

Javara’s unqiue model and strategy to integrate clinical research within the care continuum, aligning with population health strategies of academic medical centers and healthcare systems, stands to revolutionize the way in which clinical trials are conducted.  Javara’s CEO and Board Chair, Jennifer Byrne, stated “On this journey of bringing more patients to clinical trials as part of their care, Devana’s IGNITE for sites platform is a key technology in advancing the IRO model and offerings of Javara as a reliable solution for both healthcare and biopharmaceutical partners.”

Added Barry Lake, CEO of Devana “We are delighted to align with Javara to provide innovative solutions that drive value for patients, healthcare systems and biopharmaceutical companies and CROs. At Devana Solutions, we wanted to create a suite of products that would connect key stakeholders within the clinical trials ecosystem through better data allowing for better decisions and better outcomes.  Javara’s strategy and offerings are unique and there’s no doubt they will drive better outcomes for their health system clients, while contributing to the advancement of the drug development process. ”

Javara is currently onboarding the IGNITE software for immediate use to enhance business decisions and performance outcomes.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. To learn more visit https://devanasolutions.com

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

Devana Solutions IGNITE for sites and RealTime-CTMS announce integration to unify best in class CTMS and robust data analytics and insights.

(CHAPEL HILL, NC) October 5, 2018 – Devana Solutions, LLC (“Devana”) is pleased to announce an integration of its robust data analytics and insights software Devana IGNITE for sites  and Real Time’s intuitive CTMS software to deliver an industry leading solution for research sites.   Clinical trials can now be seamlessly managed from initial study lead through the critical study start-up stages in Devana IGNITE to patient screening, enrollment and trial completion in RealTime-CTMS.   This integration will be available for demonstration at the upcoming SCRS – Site Solutions Summit in Boca Raton, Florida starting October 12, 2018.

The combined technologies allow for a more streamlined approach to collecting data by eliminating the need to input critical study information into separate systems.  Essentially, all data captured in either system is automatically transferred into and seamlessly displayed in the other platform.

“Devana’s IGNITE for sites robust start-up and analytics platform integrated with RealTime-CTMS is a winning combination for a complete end-to end solution for managing research site operations. This will give the top research sites and site networks a significant competitive advantage in reducing cycle time for their client  Sponsors and CROs” said Barry Lake, CEO of Devana.   Added Rick Greenfield, CEO of RealTime-CTMS, “We are very excited about this powerful integration. As leading software providers in our respective spaces, sites and site networks will now be able to leverage the power of both systems to streamline the flow of data, eliminate redundant data entry and make the management of business development, contact management, start-up activities, study execution and performance metrics easier and faster.”

For a limited time, current and new customers will receive a discount on the integrated software.   Research site customers of both companies are encouraged to contact their Devana Solutions or RealTime representatives for more information or a demonstration.

Both companies are building upon their long-standing commitment to meet customer needs and develop innovative solutions to empower investigative sites to conduct the world’s best research.

About Devana Solutions, LLC.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks, advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. To learn more visit https://devanasolutions.com

CONTACT:

Matt Smith, Executive Director, Strategic Partnerships

msmith@devanasolutions.com

(608) 285-2151

 

About RealTime-CTMS:

RealTime-CTMS is designed to provide quick and easy access to study or subject information utilizing simple and intuitive navigation.   In most cases, needed information is only a few clicks away.  RealTime- stakeholders. To learn more visit https://realtime-ctms.com

CONTACT:

Rick Greenfield, CEO

rgreenfield@realtime-ctms.com

(210) 852-4310

 

1 2 3 4 5